Invesco
KRSA

Invesco’s Korsana Biosciences, Inc. Common Stock KRSA Stock Holding History

Invesco’s Portfolio KRSA Stock Details KRSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-247
Closed -$106K – 3874
2020
Q4 		$106K Buy
247
+11
+5% +$750 ﹤0.01% 3633
2020
Q3 		$201K Sell
236
-7
-3% -$800 ﹤0.01% 3455
2020
Q2 		$201K Sell
243
-28
-10% -$2.34K ﹤0.01% 3472
2020
Q1 		$100K Buy
+271
New +$19.3K ﹤0.01% 3568

Other funds holding KRSA

SPC
Slate Path Capital New York $7.22B AUM 110.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
MP
MFN Partners Boston, Massachusetts $4.83B AUM 65.74% 1-Year Est. Return
AG
Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Invesco's KRSA Position: Q1 2021 in Review

Invesco sold out of Korsana Biosciences, Inc. Common Stock (KRSA) in Q1 2021, closing a stake of 247 shares — an estimated $106K sold.

Invesco first reported a position in KRSA in Q1 2020 and held it in 4 quarters. The position peaked at $201K in Q3 2020. 69 funds tracked by Wall St. Rank hold KRSA as of Q1 2021.

  • Invesco reported no remaining Korsana Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Invesco sold 247 Korsana Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $106K.
  • Invesco first reported a position in Korsana Biosciences, Inc. Common Stock in Q1 2020 and held it in 4 quarters.
  • Invesco's Korsana Biosciences, Inc. Common Stock position peaked at $201K in Q3 2020.
  • 69 funds tracked by Wall St. Rank held Korsana Biosciences, Inc. Common Stock as of Q1 2021.

Based on Invesco's 13F filing for Q1 2021, filed 17 May 2021.